Want to see CNC full AI Analyst Report?
CNC Stock Chart & Stats
$65.00
$0.16(0.25%)
At close: 4:00 PM EDT
$65.00
$0.16(0.25%)
Day’s Range― - ―
52-Week Range$31.63 - $71.71
Previous CloseN/A
Volume986.83K
Average Volume (3M)4.57M
Market Cap
$34.70B
Enterprise Value$48.14B
Total Cash (Recent Filing)$27.06B
Total Debt (Recent Filing)$16.11B
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Oct 27, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.40
Shares Outstanding493,995,000
10 Day Avg. Volume4,077,824
30 Day Avg. Volume4,566,346
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.10
P/FCF Ratio4.68
Enterprise Value/Market Cap1.39
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit1.54
Enterprise Value/Ebitda-17.63
Forecast
1Y Price Target
$72.92Price Target Upside12.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)4.87
Revenue Forecast (FY)$196.55B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationRobust operating and free cash flow provides internal funding for claims, technology, debt reduction, and other priorities even while reported net income is negative. This supports liquidity and financial resilience, although the company has experienced meaningful year-to-year cash flow volatility.
Margin RecoveryImproving health benefits ratios across key businesses indicate better medical cost management and progress toward restoring profitability. The raised earnings outlook, Marketplace improvement, and stronger PDP expectations suggest operating initiatives can support earnings recovery over the next several quarters.
Improving Debt ProfileRemoving the remaining 2027 notes simplifies Centene’s maturity profile and follows earlier debt reduction and improving debt-to-capital metrics. A cleaner balance sheet can preserve financial flexibility for healthcare investments, operational needs, and shareholder-oriented capital allocation.
Bears Say
Recent Profitability DeteriorationThe recent shift from prior profitability to operating and net losses weakens earnings quality and reduces the company’s ability to convert its large revenue base into shareholder returns. Sustained losses would constrain reinvestment and make future performance more dependent on successful margin restoration.
Medicaid Membership AttritionMedicaid enrollment declines can reduce the scale of Centene’s largest business and create pressure on premium revenue, fixed-cost absorption, and market position. The associated increase in expansion-population acuity also raises the risk that fewer members do not translate proportionally into lower medical costs.
Marketplace Regulatory ExposureCentene’s Marketplace operations are exposed to federal eligibility and anti-fraud actions that can reduce enrollment and alter the risk pool. Large-scale cancellations may create membership volatility, affect premium and subsidy-supported revenue, and complicate planning for Marketplace margins over coming quarters.
Centene News
CNC FAQ
What was Centene’s price range in the past 12 months?
Centene lowest stock price was $31.63 and its highest was $71.71 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is $34.70B.
When is Centene’s upcoming earnings report date?
Centene’s upcoming earnings report date is Oct 27, 2026 which is in 5 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Jul 28, 2026. The company reported $2.51 earnings per share for the quarter, beating the consensus estimate of $1.085 by $1.425.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene does not currently pay dividends.
What is Centene’s EPS estimate?
Centene’s EPS estimate is 0.1.
How many shares outstanding does Centene have?
Centene has 493,995,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of $2.51 in its last earnings report, beating expectations of $1.085. Following the earnings report the stock price went down -0.265%.
Which hedge fund is a major shareholder of Centene?
Currently, no hedge funds are holding shares in CNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Centene Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$72.92 (12.19% Upside)
$72.92 (12.19% Upside)
Blogger Sentiment
Bullish
CNC Sentiment 82%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.57%
12-Months-Change
Fundamentals
Return on Equity
-24.03%
Trailing 12-Months
Asset Growth
-3.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Centene
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
CNC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid financial momentum and tangible operational progress: a Q2 EPS beat, raised full-year EPS guidance, margin improvements in Marketplace and PDP, better-than-expected state rate development for Medicaid, strong cash flow and balance-sheet improvements, and measurable cost-management wins (including AI-enabled initiatives). However, the company faces meaningful near-term headwinds: membership attrition (especially in Medicaid expansion), acuity shifts that could pressure medical cost ratios, regulatory/program uncertainty (OB3, STARS, eligibility verification), and a portion of Q2 upside tied to nonrecurring prior-period settlements. On balance, the positive guidance revisions, margin recoveries in key segments, cash and debt improvement, and demonstrated operating discipline outweigh the near-term risks flagged by management.View all CNC earnings summariesCNC Revenue Breakdown
88.08% Premium
1.55% Service
10.37% Premium tax
CNC Stock 12 Month Forecast
Average Price Target
$72.92
▲(12.19% Upside)
Technical Analysis
Ownership Overview
0.74% Insiders
22.18% Mutual Funds
2.58% Other Institutional Investors
41.92% Public Companies and Individual Investors